Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury

Critical Care Medicine

Volumn 36, Issue 6, 2008, Pages 1880-1885

  Chen, Chung Ming ^a   Chou, Hsiu Chu ^b   Wang, Leng Fang ^b   Lang, Yaw Dong ^c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiotensin; Bronchoalveolar lavage; Coagulation; Fibrinolysis

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; FIBRINOLYSIS; GENE EXPRESSION; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG VENTILATION; MALE; NONHUMAN; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RAT; TIDAL VOLUME; VENTILATOR; ANIMAL; BLOOD; GENETICS; LUNG; LUNG ALVEOLUS; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VENTILATOR ASSOCIATED PNEUMONIA;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; FIBRINOLYSIS; LUNG; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PNEUMONIA, VENTILATOR-ASSOCIATED; POLYMERASE CHAIN REACTION; POSITIVE-PRESSURE RESPIRATION; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIDAL VOLUME;

EID: 45149103970     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31817c911d     Document Type: Article

References (37)

1. Streiter RM, Lynch JP. Complications in the ventilated patients. Clin Chest Med 1998; 9:127-139
2. Dreyfuss D, Basset G, Soler P, et al, Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985; 132:880-884
3. Parker JC, Hernandez LA, Peey KJ. Mechanisms of ventilator-induced lung injury. Crit Care Med 1993; 21:131-143
4. Tremblay LN, Slutsky AS. Ventilator-induced injury: barotrauma to biotrauma. Proc Assoc Am Physicians 1998; 110:482-488
5. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003; 31(Suppl 4):S213-S220
6. Dahlem P, Bos AP, Haitsma JJ, et al. Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation. Intensive Care Med 2005; 31:724-732
7. Dahlem P, Bos AP, Haitsma JJ, et al. Mechanical ventilation affects alveolar fibrinolysis in LPS-induced lung injury. Eur Respir J 2006; 28:992-998
8. Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome: Fibrosis in the fast lane. Thorax 1998; 53:815-817
9. Olman M, Mackman N, Gladson C, et al. Changes in procoagulant and fibrinolytic gene expression during bleomycin induced lung injury in the mouse. J Clin Invest 1995; 96:1621-1630
10. Olman MA, Simmons WL, Pollman DJ, et al. Polymerization of fibrinogen in murine bleomycin-induced lung injury. Am J Physiol 1996; 271:L519-L526
11. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88:1067-1072
12. Filippatos G, Tilak M, Pinillos H, et al. Regulation of apoptosis by angiotensin II in the heart and lungs. Int J Mol Med 2001; 7:273-280
13. Ridker PM, Gaboury CL, Conlin PR, et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II-evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation 1993; 87:1969-1973
14. Van Leeuven RTJ, Kol A, Andreotti F, et al. Angiotensin II increases plasminogen activator inhibitor type I and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994; 90:362-368
15. Vaughan DE, Lazos SA, Tong K, et al. Angiotensin II regulates the expression of plasminogen activator inhibitor in cultured endothelial cells. J Clin Invest 1995; 95:995-1001
16. Nishimura H, Tsuji H, Masuda H, et al. The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells. Thromb Haemost 1999; 82:1516-1521
17. Jiang JS, Wang LF, Chou HC, et al. Angiotensin-converting enzyme inhibitor captopril attenuates ventilator-induced lung injury in rats. J Appl Physiol 2007; 102:2098-2103
18. Materson BJ, Preston RA. Angiotensin-converting enzyme inhibitors in hypertension: a dozen years of experience. Arch Intern Med 1994; 154:513-523
19. Gavin TP, Spector DA, Wagner H, et al. Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J Appl Physiol 2000; 88:1690-1697
20. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193:265-275
21. Chen CM, Chou HC, Wang LF, et al. Retinoic acid fails to reverse oligohydramnios-induced pulmonary hypoplasia in fetal rats. Pediatr Res 2007; 62:553-558
22. Mikawa K, Nishina K, Tamada M, et al. Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 1998; 26:905-911
23. Nabah YN, Mateo T, Estelles R, et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 2004; 110:3581-3586
24. Waltz DA, Natkin LR, Fujita RM, et al. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vi-tronectin. J Clin Invest 1997; 100:58 - 67
25. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997; 9:714-724
26. Barazzone C, Belin D, Piguet PF, et al. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 1996; 98:2666-2673
27. Arndt PG, Young SK, Worthen GS, et al. Regulation of lipopolysaccharide- induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway. J Immunol 2005; 175:4049-4059
28. Quax PH, van den Hoogen CM, Verheijen JH, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990; 265:15560-15563
29. Chapman HA, Yang XL, Sailor LZ, et al. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages: possible role in lung injury. J Immunol 1990; 145:3398-3405
30. Gross TJ, Simon RH, Kelly CJ, et al. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am J Physiol 1991; 260: L286-L295
31. Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 1987; 109:97-104
32. Taylor FB, Kinasewitz G. Activated protein C in sepsis. J Thromb Haemost 2004; 2:708-717
33. Shua F, Kobayashia H, Fukudomeb K, et al. Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 2004; 77:208-212
34. van Hinsbergh VW, Bertina RM, van Wijngaarden A, et al. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985; 65:444-451
35. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
36. Reid IA, Morris BJ, Ganong WF. The reninangiotensin system. Annu Rev Physiol 1978; 40:377-410
37. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78:31-39